{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:26:36Z","timestamp":1748622396151,"version":"3.40.5"},"reference-count":28,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"abstract":"<jats:p>OBJECTIVE. Extracorporeal membrane oxygenation has been shown to be effective in term neonates with severe but reversible lung disease within the context of randomized, controlled trials. Extracorporeal membrane oxygenation now has been open to a wider population of infants in the United Kingdom, and other treatments have become available. The population referred for extracorporeal membrane oxygenation, therefore, has changed. The aims of this study were to (1) compare respiratory outcomes of infants who received extracorporeal membrane oxygenation in recent years with those from 10 years ago and (2) determine whether respiratory outcome varied with diagnostic group.<\/jats:p>\n               <jats:p>METHODS. All infants who were referred to a single extracorporeal membrane oxygenation center and were &amp;lt;12 months old during a 7-year period were eligible. One year after extracorporeal membrane oxygenation, lung volume, airway conductance, maximum expiratory flow, and indices of tidal breathing were measured.<\/jats:p>\n               <jats:p>RESULTS. A total of 106 infants (77% of those eligible) were tested, and results were compared with those of 51 infants referred for extracorporeal membrane oxygenation as part of the original United Kingdom extracorporeal membrane oxygenation trial. Lung volume was not different, but there was a strong trend for the infants who were seen in more recent years to have better forced expiratory flow and specific airway conductance. Restricting analysis to the major subgroup (meconium aspiration) confirmed these findings. When divided into diagnostic subgroups, infants who required extracorporeal membrane oxygenation for respiratory distress syndrome or who were &amp;gt;2 weeks old when extracorporeal membrane oxygenation was commenced had a poorer respiratory outcome than others.<\/jats:p>\n               <jats:p>CONCLUSIONS. The respiratory outcome of infants who were treated beyond the tightly regulated criteria of the United Kingdom trial remains good and even shows a trend toward improvement. Certain subgroups require extracorporeal membrane oxygenation for longer and have poorer pulmonary function when followed up.<\/jats:p>","DOI":"10.1542\/peds.2006-1955","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T00:53:07Z","timestamp":1190076787000},"page":"e762-e768","source":"Crossref","is-referenced-by-count":7,"title":["How Does the Changing Profile of Infants Who Are Referred for Extracorporeal Membrane Oxygenation Affect Their Overall Respiratory Outcome?"],"prefix":"10.1542","volume":"120","author":[{"given":"Caroline S.","family":"Beardsmore","sequence":"first","affiliation":[{"name":"Department of Infection, Immunity and Inflammation, University of Leicester and Institute of Lung Health, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Westaway","sequence":"additional","affiliation":[{"name":"Department of Infection, Immunity and Inflammation, University of Leicester and Institute of Lung Health, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilliary","family":"Killer","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Glenfield Hospital, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Firmin","sequence":"additional","affiliation":[{"name":"Department of Infection, Immunity and Inflammation, University of Leicester and Institute of Lung Health, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitesh","family":"Pandya","sequence":"additional","affiliation":[{"name":"Department of Infection, Immunity and Inflammation, University of Leicester and Institute of Lung Health, Leicester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2007,10,1]]},"reference":[{"key":"2021120902303087800_R1","doi-asserted-by":"crossref","unstructured":"Green TP, Timmons OD, Fackler JC, Moler FW, Thompson AE, Sweeney MF. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Crit Care Med.\u20081996;24:323\u2013329","DOI":"10.1097\/00003246-199602000-00023"},{"key":"2021120902303087800_R2","doi-asserted-by":"crossref","unstructured":"The UK Collaborative ECMO Trial Group. UK Collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet.\u20081996;348:75\u201382","DOI":"10.1016\/S0140-6736(96)04100-1"},{"key":"2021120902303087800_R3","doi-asserted-by":"crossref","unstructured":"Beardsmore CS, Dundas I, Poole K, Enock K, Stocks J. Respiratory function in survivors of the UK ECMO Trial. Am J Respir Crit Care Med.\u20082000;161:1129\u20131135","DOI":"10.1164\/ajrccm.161.4.9811093"},{"key":"2021120902303087800_R4","doi-asserted-by":"crossref","unstructured":"McNally H, Bennett CC, Elbourne D, Field DJ; UK Collaborative ECMO Trial Group. United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation: follow-up to age 7 years. Pediatrics.\u20082006;117:845\u2013854","DOI":"10.1542\/peds.2005-1167"},{"key":"2021120902303087800_R5","doi-asserted-by":"crossref","unstructured":"Hintz SR, Suttner DM, Sheehan AM, Rhine WD, Van Meurs KP. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization. Pediatrics.\u20082000;106:1339\u20131343","DOI":"10.1542\/peds.106.6.1339"},{"key":"2021120902303087800_R6","doi-asserted-by":"crossref","unstructured":"Roy BJ, Rycus P, Conrad SA, Clark RH. The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry. Pediatrics.\u20082000;106:1334\u20131338","DOI":"10.1542\/peds.106.6.1334"},{"key":"2021120902303087800_R7","doi-asserted-by":"crossref","unstructured":"Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the Neonatal Inhaled Nitric Oxide Study Group (NINOS). J Pediatr.\u20082000;136:611\u2013617","DOI":"10.1067\/mpd.2000.104826"},{"key":"2021120902303087800_R8","doi-asserted-by":"crossref","unstructured":"Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med.\u20082000;342:469\u2013474","DOI":"10.1056\/NEJM200002173420704"},{"key":"2021120902303087800_R9","doi-asserted-by":"crossref","unstructured":"Lonnqvist PA. Efficacy and economy of inhaled nitric oxide in neonates accepted for extracorporeal membrane oxygenation. Acta Physiol Scand.\u20081999;167:175\u2013179","DOI":"10.1046\/j.1365-201x.1999.00586.x"},{"key":"2021120902303087800_R10","doi-asserted-by":"crossref","unstructured":"Angus DC, Clermont G, Watson RS, Linde-Zwirble WT, Clark RH, Roberts MS. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics.\u20082003;112:1351\u20131360","DOI":"10.1542\/peds.112.6.1351"},{"key":"2021120902303087800_R11","doi-asserted-by":"crossref","unstructured":"Sebald M, Friedlich P, Burns C, et al. Risk of need for extracorporeal membrane oxygenation support in neonates with congenital diaphragmatic hernia treated with inhaled nitric oxide. J Perinatol.\u20082004;24:143\u2013146","DOI":"10.1038\/sj.jp.7211033"},{"key":"2021120902303087800_R12","doi-asserted-by":"crossref","unstructured":"Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev.\u20082001;(4):CD000399","DOI":"10.1002\/14651858.CD000399"},{"key":"2021120902303087800_R13","doi-asserted-by":"crossref","unstructured":"Field D, Elbourne D, Hardy P, et al. Neonatal ventilation with inhaled nitric oxide vs ventilatory support without inhaled nitric oxide for infants with severe respiratory failure born at or near term: the INNOVO multicentre randomised controlled trial. Neonatology.\u20082007;91:73\u201382","DOI":"10.1159\/000097123"},{"key":"2021120902303087800_R14","doi-asserted-by":"crossref","unstructured":"Dundas I, Beardsmore C, Wellman T, Stocks J. A collaborative study of infant respiratory function testing. Eur Respir J.\u20081998;12:944\u2013953","DOI":"10.1183\/09031936.98.12040944"},{"key":"2021120902303087800_R15","doi-asserted-by":"crossref","unstructured":"Sly PD, Tepper R, Henschen M, Gappa M, Stocks J; ERS\/ATS Task Force on Standards for Infant Respiratory Function Testing. Tidal forced expirations. Eur Respir J.\u20082000;16:741\u2013748","DOI":"10.1034\/j.1399-3003.2000.16d29.x"},{"key":"2021120902303087800_R16","doi-asserted-by":"crossref","unstructured":"Henschen M, Stocks J, Hoo AF, Dixon P. Analysis of forced expiratory maneuvres from raised lung volumes in preterm infants. J Appl Physiol.\u20081998;85:1989\u20131997","DOI":"10.1152\/jappl.1998.85.5.1989"},{"key":"2021120902303087800_R17","doi-asserted-by":"crossref","unstructured":"Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J.\u20081995;8:492\u2013506","DOI":"10.1183\/09031936.95.08030492"},{"key":"2021120902303087800_R18","doi-asserted-by":"crossref","unstructured":"Hoo A-F, Dezateux C, Hanrahan JP, Cole TJ, Tepper RS, Stocks J. Sex-specific prediction equations for VmaxFRC in infancy: a multicenter collaborative study. Am J Respir Crit Care Med.\u20082002;165:1084\u20131092","DOI":"10.1164\/ajrccm.165.8.2103035"},{"key":"2021120902303087800_R19","doi-asserted-by":"crossref","unstructured":"Khan JY, Kerr SJ, Tometzki A, et al. Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report. Arch Dis Child Fetal Neonatal Ed.\u20081995;73:F91\u2013F94","DOI":"10.1136\/fn.73.2.F91"},{"key":"2021120902303087800_R20","doi-asserted-by":"crossref","unstructured":"Steinhorn RH, Green TP. Use of extracorporeal membrane oxygenation in the treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983\u20131988. J Pediatr.\u20081990;116:338\u2013342","DOI":"10.1016\/S0022-3476(05)82817-3"},{"key":"2021120902303087800_R21","doi-asserted-by":"crossref","unstructured":"Flamant C, Hallalel F, Nolent P, Chevalier JY, Renolleau S. Severe respiratory syncytial virus bronchiolitis in children: from short mechanical ventilation to extracorporeal membrane oxygenation. Eur J Pediatr.\u20082005;164:93\u201398","DOI":"10.1007\/s00431-004-1580-0"},{"key":"2021120902303087800_R22","doi-asserted-by":"crossref","unstructured":"Pooboni S, Roberts N, Westrope C, et al. Extracorporeal life support in pertussis. Pediatr Pulmonol.\u20082003;36:310\u2013315","DOI":"10.1002\/ppul.10351"},{"key":"2021120902303087800_R23","doi-asserted-by":"crossref","unstructured":"Petrou S, Bischof M, Bennett C, Elbourne D, Field D, McNally H. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial. Pediatrics.\u20082006;117:1640\u20131649","DOI":"10.1542\/peds.2005-1150"},{"key":"2021120902303087800_R24","doi-asserted-by":"crossref","unstructured":"Macfarlane PI, Heaf DP. Pulmonary function in children after neonatal meconium aspiration syndrome. Arch Dis Child.\u20081988;63:368\u2013372","DOI":"10.1136\/adc.63.4.368"},{"key":"2021120902303087800_R25","doi-asserted-by":"crossref","unstructured":"Swaminathan S, Quinn J, Stabile MW, Bader D, Platzker AC, Keens TG. Long-term pulmonary sequelae of meconium aspiration syndrome. J Pediatr.\u20081989;114:356\u2013361","DOI":"10.1016\/S0022-3476(89)80551-7"},{"key":"2021120902303087800_R26","doi-asserted-by":"crossref","unstructured":"Hamutcu R, Nield TA, Garg M, Keens TG, Platzker AC. Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. Pediatrics.\u20082004;114:1292\u20131296","DOI":"10.1542\/peds.2003-1080-L"},{"key":"2021120902303087800_R27","unstructured":"Beardsmore C, Laverty A, King C, Jotham D, Paton J, Stocks J. Randomized controlled trial of neonatal ECMO: seven-year respiratory follow-up [abstract]. Am J Respir Crit Care Med.\u20082004;169:A379"},{"key":"2021120902303087800_R28","doi-asserted-by":"crossref","unstructured":"Clarke JR, Aston H, Silverman M. Evaluation of a tidal expiratory flow index in healthy and diseased infants. Pediatr Pulmonol.\u20081994;17:285\u2013290","DOI":"10.1002\/ppul.1950170504"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/4\/e762\/1176056\/zpe0100700e762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/4\/e762\/1176056\/zpe0100700e762.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T13:24:40Z","timestamp":1639056280000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/4\/e762\/71274\/How-Does-the-Changing-Profile-of-Infants-Who-Are"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2007,10,1]]},"published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-1955","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2007,10,1]]}}}